TRex Bio, Inc (TRXB) Stock
Key stats
- Market cap
- $391.10M
- Price / Earnings ratio
- -10.4x
- EPS (TTM)
- -$8.59
- Volume
- Loading
- 52-week high
- $16.56
- 52-week low
- $12.50
Source: third-party data provider, as of November 13, 2026
Compare with TRXB
Recent news
No recent news
Analyst ratings
Analyst consensus: Buy
Based on 5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
About TRex Bio, Inc
TRex Bio, Inc. is a clinical-stage biopharmaceutical company focused on tissue Treg biology. It discovers and develops immunoregulatory medicines designed to restore immune balance and promote tissue repair, addressing the unmet needs of patients with autoimmune and inflammatory diseases.
Fundamentals
Valuation
Trading
Source: third-party data provider, as of November 13, 2026
Analyst views
5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $20.00
- Average
- $29.25
- High
- $39.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.9 | +4.5 |



